CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma

CHI3L1 (YKL40) is a secreted glycoprotein and elevated serum CHI3L1 level has been proved to be associated with poor prognosis in many human cancers. However, the mechanism of how CHI3L1 causes poor prognosis in cancers is still unknown. Here, considering that CHI3L1 is a liver specific/enriched pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Qing-Chong, Wang, Lin, Jin, Shan-Shan, Liu, Guan-Feng, Liu, Jie, Ma, Liang, Mao, Rui-Fang, Ma, Ying-Ying, Zhao, Na, Chen, Ming, Lin, Biao-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177412/
https://www.ncbi.nlm.nih.gov/pubmed/30301907
http://dx.doi.org/10.1038/s41598-018-33239-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177412/
https://www.ncbi.nlm.nih.gov/pubmed/30301907
http://dx.doi.org/10.1038/s41598-018-33239-8

Ejemplares similares